Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam · Delayed Price · Currency is VND 18,400
0.00 (0.00%)
At close: May 13, 2026
HNX:MED Market Cap
HNX:MED has a market cap or net worth of 228.34 billion as of August 12, 2026. Its market cap has decreased by -32.60% in one year.
Market Cap
228.34B
Enterprise Value
231.16B
Revenue
291.40B
Ranking
n/a
PE Ratio
9.51
Stock Price
18,400.00
ChartMarket Cap Chart
Since March 18, 2020, HNX:MED's market cap has decreased from 307.72B to 228.34B, a decrease of -25.80%. That is a compound annual growth rate of -4.73%.
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 228.34B | -21.70% |
| Dec 31, 2025 | 291.64B | -12.96% |
| Dec 27, 2023 | 335.07B | 28.57% |
| Dec 26, 2022 | 260.61B | 38.79% |
| Dec 31, 2021 | 187.77B | -23.33% |
| Dec 24, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Central Pharmaceutical Joint Stock Company No3 | 1.30T |
| Pharmedic Pharmaceutical Medicinal JSC | 1.21T |
| Vidipha Central Pharmaceutical JSC | 821.50B |
| Ben Tre Pharmaceutical JSC | 287.77B |
| Vimedimex Medi-Pharma JSC | 216.94B |
| Phong Phu Pharmaceutical JSC | 162.80B |
| American Vietnamese Biotech Incorporation | 157.33B |
| Tipharco Pharmaceutical JSC | 152.15B |